Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol.
about
Vitamin D and the skin: Focus on a complex relationship: A review1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitisVitamin effects on the immune system: vitamins A and D take centre stage.Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expressionVitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.The influence of nutritional factors on the prognosis of multiple sclerosis.Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunityDietary vitamin D and vitamin D receptor level modulate epithelial cell proliferation and apoptosis in the prostate.Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model.Evaluation of Vitamin D Status in Newly Diagnosed Pemphigus Vulgaris Patients.1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophages.Autoimmune prostatitis: state of the art.Vitamin D and human health: lessons from vitamin D receptor null mice.Vitamin D and immune function.Vitamin D receptor agonists in the treatment of autoimmune diseases: selective targeting of myeloid but not plasmacytoid dendritic cells.Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions.Control of autoimmune diseases by the vitamin D endocrine system.Targeted overexpression of vav3 oncogene in prostatic epithelium induces nonbacterial prostatitis and prostate cancer.Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response.Chronic inflammation in the pathogenesis of benign prostatic hyperplasia.Mycobacterium tuberculosis, autoimmunity, and vitamin D.Anti-Inflammatory Effect of Dialyzable Leukocyte Extract in Autoimmune Prostatitis: Evaluation in Animal Model.Impact of vitamin D on immune function: lessons learned from genome-wide analysis.Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia.Hypovitaminosis D as predisposing factor for atrophic type A gastritis: a case-control study and review of the literature on the interaction of Vitamin D with the immune system.Inflammation and benign prostatic hyperplasia: clinical implications.An update on vitamin D and human immunity.Vitamin D receptor agonists target CXCL10: new therapeutic tools for resolution of inflammation.Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection.Vitamin D Level Between Calcium-Phosphorus Homeostasis and Immune System: New Perspective in Osteoporosis.HDAC inhibitor MS-275 attenuates the inflammatory reaction in rat experimental autoimmune prostatitis.Immunomodulatory effects of Vitamin D in multiple sclerosis.Immunological Mechanisms Underlying Chronic Pelvic Pain and Prostate Inflammation in Chronic Pelvic Pain Syndrome.The effect of 1, 25(OH)2 D3 (calcitriol) alone and in combination with all-trans retinoic acid on ROR-γt, IL-17, TGF-β, and FOXP3 gene expression in experimental autoimmune encephalomyelitis.Environmental control of Th17 differentiation.Il-1 beta-induced post-transition effect of NF-kappaB provides time-dependent wave of signals for initial phase of intrapostatic inflammation.Impaired regulatory T-cell homeostasis due to vitamin D deficiency in undifferentiated connective tissue disease.1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis.The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.Chronic Pelvic Pain Development and Prostate Inflammation in Strains of Mice With Different Susceptibility to Experimental Autoimmune Prostatitis.
P2860
Q26773618-D82F66C6-D45B-4307-A0EE-30F847576E89Q28475567-80D6E97D-14FA-4F83-A9D1-E2625BC43BACQ34005584-EB50C0EC-4777-495F-8847-EC3538A20D62Q34386094-4FC2FB15-44EB-49F3-A185-BB71BF478026Q34621641-3124B950-0349-46BD-89BB-6FCCA428C196Q34643392-E9ABF799-9808-4390-805F-DF8C22E0AD93Q34739582-08294981-9375-43F5-9DA9-214201D4A51DQ35281504-41177F4B-3CC5-40E0-B369-D61CC3054D9BQ35322827-D08C9618-5539-4B70-A814-7D98580AA872Q35666710-4967BE49-57DB-488C-B629-01951AEC050AQ36718044-FF30C560-93DE-4B47-8D9D-33E721B6ED02Q36884521-455F30F5-CB5C-4B11-8A2E-291B01152DD0Q36973933-E27082F4-C761-4F9A-9421-01ABD47AE17CQ37083785-B14DE4DD-7429-434C-9ACE-0F48683CE0ADQ37091003-88B99B85-387E-42B5-8DBE-F564A6034E64Q37101754-07CEB318-03FD-4B73-AB15-DFC645BBFD96Q37204961-D5D153C1-52A8-47C9-A789-36405A9F0E74Q37315118-42387C47-EA78-4474-874F-11923E51889DQ37374447-B1BC38B4-D15F-413E-AD1E-548CD03BF011Q37512391-BD8569FD-3AC0-4991-AB94-8368706D47B6Q37526582-CC4DC7B4-3E31-4734-BA21-AB2E3E6E5305Q37720993-697869E5-FD39-44EF-8EFA-47E981A3C9A5Q37725587-83F254DB-9904-4B66-8C30-7E1F14BED730Q37732379-1A2DE539-2121-4AB8-8F03-943F3AF4E5EDQ37834399-656C599D-B126-42AC-A054-DB0F1E1C7B1CQ37868983-8C5A0E25-B6FE-4C61-B3BD-8BFCECF32FC1Q37945341-C0ACF84F-DC32-4D6F-8BEE-404C45A51023Q38108294-DC191C22-D038-40D2-A50E-C82DED33691BQ38517180-3B569A44-FF9C-462C-BEB7-1E41BD78E2E0Q38979293-91847043-998F-4561-86CE-467FFE5F1CB2Q39549290-635A1CD1-2297-426A-99EE-947F371AA52FQ39868289-2E7D96BB-D464-4E37-A1F8-8FE5CD1C1B2EQ40086340-5C3EFC2B-9ED8-43EF-8DC2-866C0B0E44E6Q40416300-A290FA7F-79E5-4213-9F98-99B7BA2C1638Q41110001-43F8F7A8-F6E4-4CDD-9B5D-26F2619E58CCQ42109467-4D94C891-63B5-4814-B27A-06C792D8D8BAQ42976139-F1F12A17-2A1A-48FE-AF27-F922B131B5B3Q43205828-B61E12AE-75A7-4C2A-816D-B248EE6AB33EQ46183765-B18CFA20-AD2C-467F-A497-3AB3A7D0EC71Q46482567-DBE4B320-E250-4B99-948F-18FD61D2D673
P2860
Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Treatment of experimental auto ...... receptor agonist elocalcitol.
@en
Treatment of experimental auto ...... receptor agonist elocalcitol.
@nl
type
label
Treatment of experimental auto ...... receptor agonist elocalcitol.
@en
Treatment of experimental auto ...... receptor agonist elocalcitol.
@nl
prefLabel
Treatment of experimental auto ...... receptor agonist elocalcitol.
@en
Treatment of experimental auto ...... receptor agonist elocalcitol.
@nl
P2093
P1476
Treatment of experimental auto ...... receptor agonist elocalcitol.
@en
P2093
Chiara Cossetti
Claudio Doglioni
Francesca Aquilano
Francesca Sanvito
Luciano Adorini
Roberto Mariani
Susana Amuchastegui
P304
P356
10.4049/JIMMUNOL.177.12.8504
P407
P577
2006-12-01T00:00:00Z